Indian companies race to produce generic Ozempic as patent expires

As the patent for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic versions of the drug. #cnn #news